Urru, S. A. M., Alegiani, S. S., Guella, A., Traversa, G., & Campomori, A. (2021). Safety of switching between rituximab biosimilars in onco-hematology. Nature Portfolio.
Cita Chicago Style (17a ed.)Urru, Silvana A. M., Stefania Spila Alegiani, Anna Guella, Giuseppe Traversa, y Annalisa Campomori. Safety of Switching Between Rituximab Biosimilars in Onco-hematology. Nature Portfolio, 2021.
Cita MLA (8a ed.)Urru, Silvana A. M., et al. Safety of Switching Between Rituximab Biosimilars in Onco-hematology. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.